Neurocrine Biosciences (NBIX) Fails to deliver data

Key failure to deliver metrics for Neurocrine Biosciences :

• Last SEC data release: 2025-11-14
• Last 15 days FTD volume: A$2.57 M
• Last 3 months FTD volume: A$2.71 M
• Last 12 months FTD volume: A$30.9 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Neurocrine Biosciences (NBIX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Neurocrine Biosciences (NBIX) - since 2013

Neurocrine Biosciences (NBIX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Repligen RGEN	A$0.92 M	A$16.71 M	🇺🇸 USA
Royalty Pharma RPRX	A$0.14 B	A$0.20 B	🇬🇧 UK
Palatin Technologies PTN	A$1.61 M	A$4.01 M	🇺🇸 USA
Eli Lilly LLY	A$0.21 B	A$0.37 B	🇺🇸 USA
AbbVie ABBV	A$21.44 M	A$0.10 B	🇺🇸 USA
Pfizer PFE	A$24.63 M	A$0.10 B	🇺🇸 USA
ANI Pharmaceuticals ANIP	A$2.64 M	A$6.12 M	🇺🇸 USA
Athersys ATHX	A$0.09 M	A$0.71 M	🇺🇸 USA